Effect of Oral Supplements for Influenza Vaccine Response
In plain words A study of arachidonic Acid in people 60 to 70, run by Tsinghua University. It plans to enroll about 45 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 60 to 70; healthy volunteers accepted. Conditions: Influenza Vaccine Response.
- Age 60-70 years old
- Body Mass Index (BMI) 18.5-26.9 kg/m²
- No influenza vaccination in the past year
- Able to understand and sign the informed consent form, and capable of completing the full follow-up process
The exclusion criteria are on the listing.
What it tests, as registered
ARA (Arachidonic Acid) Supplementation; TUDCA (Tauroursodeoxycholic Acid) Supplementation; Placebo Supplementation; Shanghai Biological Quadrivalent Influenza Virus Inactivated Vaccine
Registered summary
The aim of this clinical trial is to explore the efficacy of fatty acid and bile acid based supplements on enhancing influenza vaccine immune response in adults aged 60-70 years. The objectives of this study are: 1. To explore the efficacy of fatty acid and bile acid based supplements on enhancing flu vaccine immune response. 2. To evaluate the safety of fatty acid and bile acid use in elders. 3. To explore the potential role of microbiota in regulating immune response. The full summary is on the listing.
Where, as registered
No US site; China (1).